메뉴 건너뛰기




Volumn 43, Issue 4, 2016, Pages 773-779

Value of 18F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment

Author keywords

18F FDG PET CT; Cytokines; Inflammation; Polymyalgia rheumatica; Therapeutic assessment

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; TOCILIZUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT;

EID: 84959158683     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-015-3287-z     Document Type: Article
Times cited : (57)

References (30)
  • 1
    • 84901731129 scopus 로고    scopus 로고
    • Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
    • PID: 24803231
    • Mori S, Koga Y. Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy. Clin Rheumatol. 2014. doi:10.1007/s10067-014-2650-y.
    • (2014) Clin Rheumatol
    • Mori, S.1    Koga, Y.2
  • 2
    • 0031243064 scopus 로고    scopus 로고
    • Prevalence of synovitis in patients with polymyalgia rheumatica and/or giant cell arteritis
    • COI: 1:STN:280:DyaK1c%2Fks1yisQ%3D%3D, PID: 9385703
    • Devauchelle V, Saraux A, Youinou P, Le Goff P. Prevalence of synovitis in patients with polymyalgia rheumatica and/or giant cell arteritis. Rev Rhum Engl Ed. 1997;64:594–5.
    • (1997) Rev Rhum Engl Ed , vol.64 , pp. 594-595
    • Devauchelle, V.1    Saraux, A.2    Youinou, P.3    Le Goff, P.4
  • 3
    • 0020374840 scopus 로고
    • Polymyalgia rheumatica: a 10 years epidemiologic and clinical study
    • COI: 1:STN:280:DyaL3s%2Fks1KitQ%3D%3D, PID: 6982645
    • Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10 years epidemiologic and clinical study. Ann Intern Med. 1982;97:672–80.
    • (1982) Ann Intern Med , vol.97 , pp. 672-680
    • Chuang, T.Y.1    Hunder, G.G.2    Ilstrup, D.M.3    Kurland, L.T.4
  • 4
    • 34248375722 scopus 로고    scopus 로고
    • Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial
    • PID: 17470831
    • Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, et al. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med. 2007;146:631–9.
    • (2007) Ann Intern Med , vol.146 , pp. 631-639
    • Salvarani, C.1    Macchioni, P.2    Manzini, C.3    Paolazzi, G.4    Trotta, A.5    Manganelli, P.6
  • 5
    • 34248351219 scopus 로고    scopus 로고
    • Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial
    • PID: 17470830
    • Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007;146:621–30.
    • (2007) Ann Intern Med , vol.146 , pp. 621-630
    • Hoffman, G.S.1    Cid, M.C.2    Rendt-Zagar, K.E.3    Merkel, P.A.4    Weyand, C.M.5    Stone, J.H.6
  • 7
    • 42749092917 scopus 로고    scopus 로고
    • Epidemiology, imaging, and treatment of giant cell arteritis
    • PID: 18378179
    • Devauchelle-Pensec V, Jousse S, Destombe C, Saraux A. Epidemiology, imaging, and treatment of giant cell arteritis. Joint Bone Spine. 2008;75(3):267–72.
    • (2008) Joint Bone Spine , vol.75 , Issue.3 , pp. 267-272
    • Devauchelle-Pensec, V.1    Jousse, S.2    Destombe, C.3    Saraux, A.4
  • 8
    • 5344221586 scopus 로고    scopus 로고
    • Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial
    • COI: 1:CAS:528:DC%2BD2cXptFOhtb4%3D, PID: 15466766
    • Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, et al. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2004;141:493–500.
    • (2004) Ann Intern Med , vol.141 , pp. 493-500
    • Caporali, R.1    Cimmino, M.A.2    Ferraccioli, G.3    Gerli, R.4    Klersy, C.5    Salvarani, C.6
  • 10
    • 77951783966 scopus 로고    scopus 로고
    • Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica
    • PID: 20439532
    • Hagihara K, Kawase I, Tanaka T, Kishimoto T. Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica. J Rheumatol. 2010;37:1075–6.
    • (2010) J Rheumatol , vol.37 , pp. 1075-1076
    • Hagihara, K.1    Kawase, I.2    Tanaka, T.3    Kishimoto, T.4
  • 12
    • 4644236004 scopus 로고    scopus 로고
    • A disease activity score for polymyalgia rheumatica
    • COI: 1:STN:280:DC%2BD2cvlt1aisQ%3D%3D, PID: 15361387
    • Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica. Ann Rheum Dis. 2004;63:1279–83.
    • (2004) Ann Rheum Dis , vol.63 , pp. 1279-1283
    • Leeb, B.F.1    Bird, H.A.2
  • 13
    • 84856530490 scopus 로고    scopus 로고
    • Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice
    • COI: 1:CAS:528:DC%2BC38XksVejtbk%3D, PID: 22174199
    • Cleuziou C, Binard A, De Bandt M, Berthelot JM, Saraux A. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice. J Rheumatol. 2012;39:310–3.
    • (2012) J Rheumatol , vol.39 , pp. 310-313
    • Cleuziou, C.1    Binard, A.2    De Bandt, M.3    Berthelot, J.M.4    Saraux, A.5
  • 14
    • 84907202542 scopus 로고    scopus 로고
    • Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
    • PID: 25113771
    • Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–58.
    • (2014) J Clin Oncol , vol.32 , pp. 3048-3058
    • Barrington, S.F.1    Mikhaeel, N.G.2    Kostakoglu, L.3    Meignan, M.4    Hutchings, M.5    Müeller, S.P.6
  • 15
    • 33746539507 scopus 로고    scopus 로고
    • Monitoring chemotherapy and radiotherapy of solid tumors
    • PID: 16688451
    • Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging. 2006;33:27–37.
    • (2006) Eur J Nucl Med Mol Imaging , vol.33 , pp. 27-37
    • Weber, W.A.1    Wieder, H.2
  • 16
    • 84868198334 scopus 로고    scopus 로고
    • FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis
    • PID: 22820649
    • Nanni C, Boriani L, Salvadori C, Zamparini E, Rorato G, Ambrosini V, et al. FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging. 2012;39:1538–44.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , pp. 1538-1544
    • Nanni, C.1    Boriani, L.2    Salvadori, C.3    Zamparini, E.4    Rorato, G.5    Ambrosini, V.6
  • 17
    • 84908490941 scopus 로고    scopus 로고
    • Utility of FDG-PET-CT scanning in assessing the extent of disease activity and response to treatment in sarcoidosis
    • PID: 25378838
    • Guleria R, Jyothidasan A, Madan K, Mohan A, Kumar R, Bhalla AS, et al. Utility of FDG-PET-CT scanning in assessing the extent of disease activity and response to treatment in sarcoidosis. Lung India. 2014;31:323–30.
    • (2014) Lung India , vol.31 , pp. 323-330
    • Guleria, R.1    Jyothidasan, A.2    Madan, K.3    Mohan, A.4    Kumar, R.5    Bhalla, A.S.6
  • 18
    • 84906822471 scopus 로고    scopus 로고
    • Clinical value of whole-body PET/CT in patients with active rheumatic diseases
    • PID: 25606590
    • Yamashita H, Kubota K, Mimori A. Clinical value of whole-body PET/CT in patients with active rheumatic diseases. Arthritis Res Ther. 2014;16:423.
    • (2014) Arthritis Res Ther , vol.16 , pp. 423
    • Yamashita, H.1    Kubota, K.2    Mimori, A.3
  • 19
    • 0033982778 scopus 로고    scopus 로고
    • Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch
    • COI: 1:STN:280:DC%2BD3c7os1Ghuw%3D%3D, PID: 10723979
    • Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–9.
    • (2000) Am J Med , vol.108 , pp. 246-249
    • Blockmans, D.1    Stroobants, S.2    Maes, A.3    Mortelmans, L.4
  • 20
    • 34047118153 scopus 로고    scopus 로고
    • Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients
    • COI: 1:STN:280:DC%2BD2s7nvFSrtw%3D%3D
    • Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford). 2007;46:672–7.
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 672-677
    • Blockmans, D.1    De Ceuninck, L.2    Vanderschueren, S.3    Knockaert, D.4    Mortelmans, L.5    Bobbaers, H.6
  • 22
    • 84875515028 scopus 로고    scopus 로고
    • Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis
    • PID: 22749663
    • Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, et al. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Joint Bone Spine. 2013;80:171–7.
    • (2013) Joint Bone Spine , vol.80 , pp. 171-177
    • Yamashita, H.1    Kubota, K.2    Takahashi, Y.3    Minamimoto, R.4    Morooka, M.5    Kaneko, H.6
  • 23
    • 84870368569 scopus 로고    scopus 로고
    • Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis
    • PID: 22205118
    • Yamashita H, Kubota K, Takahashi Y, Minaminoto R, Morooka M, Ito K, et al. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol. 2012;22:705–11.
    • (2012) Mod Rheumatol , vol.22 , pp. 705-711
    • Yamashita, H.1    Kubota, K.2    Takahashi, Y.3    Minaminoto, R.4    Morooka, M.5    Ito, K.6
  • 25
    • 80455164741 scopus 로고    scopus 로고
    • Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis
    • PID: 21559981
    • Besson FL, Parienti JJ, Bienvenu B, Prior JO, Costo S, Bouvard G, et al. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , pp. 1764-1772
    • Besson, F.L.1    Parienti, J.J.2    Bienvenu, B.3    Prior, J.O.4    Costo, S.5    Bouvard, G.6
  • 27
    • 84881542249 scopus 로고    scopus 로고
    • Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature
    • COI: 1:CAS:528:DC%2BC3sXivFyisbY%3D, PID: 23433960
    • Macchioni P, Boiardi L, Catanoso M, Pulsatelli L, Pipitone N, Meliconi R, et al. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum. 2013;43:113–8.
    • (2013) Semin Arthritis Rheum , vol.43 , pp. 113-118
    • Macchioni, P.1    Boiardi, L.2    Catanoso, M.3    Pulsatelli, L.4    Pipitone, N.5    Meliconi, R.6
  • 28
    • 84865182162 scopus 로고    scopus 로고
    • The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT
    • COI: 1:CAS:528:DC%2BC38XhtFagu7nN
    • Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford). 2012;51:1484–91.
    • (2012) Rheumatology (Oxford) , vol.51 , pp. 1484-1491
    • Okamura, K.1    Yonemoto, Y.2    Arisaka, Y.3    Takeuchi, K.4    Kobayashi, T.5    Oriuchi, N.6
  • 29
    • 54949135724 scopus 로고    scopus 로고
    • An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis
    • COI: 1:STN:280:DC%2BD1cnkvFeltg%3D%3D, PID: 18821687
    • Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958–67.
    • (2008) Arthritis Rheum , vol.58 , pp. 2958-2967
    • Brown, A.K.1    Conaghan, P.G.2    Karim, Z.3    Quinn, M.A.4    Ikeda, K.5    Peterfy, C.G.6
  • 30
    • 60149109335 scopus 로고    scopus 로고
    • Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans
    • COI: 1:CAS:528:DC%2BD1MXjvFOht7w%3D, PID: 19076727
    • Kanstrup IL, Klausen TL, Bojsen-Møller J, Magnusson P, Zerahn B. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans. Clin Physiol Funct Imaging. 2009;29(2):108–13.
    • (2009) Clin Physiol Funct Imaging , vol.29 , Issue.2 , pp. 108-113
    • Kanstrup, I.L.1    Klausen, T.L.2    Bojsen-Møller, J.3    Magnusson, P.4    Zerahn, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.